Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using Biosimulation PRINCETON, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the Company has been awarded a grant from the U.S. Food and Drug...

US FDA Grants Mexiletine Orphan Drug Designation US FDA Grants Mexiletine Orphan Drug Designation Zug, Switzerland, 8 June 2019: Lupin is pleased to announce that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD)...

NABP Receives FDA Funding to Develop Data-Sharing System for Improved Oversight of Compounding Pharmacies MOUNT PROSPECT, IL, Oct. 02, 2019 (GLOBE NEWSWIRE) -- The National Association of Boards of Pharmacy® (NABP®) is pleased to announce it has been awarded funding from Food and Drug Administration...